Published in Clin Exp Nephrol on February 11, 2014
Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation. Fibrogenesis Tissue Repair (2014) 0.80
Hypertension in the Pediatric Kidney Transplant Recipient. Front Pediatr (2017) 0.75
Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J (2006) 17.53
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
The natural history of chronic allograft nephropathy. N Engl J Med (2003) 8.70
Kidney transplantation under FK 506. JAMA (1990) 7.45
Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65
Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol (2004) 5.43
Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension (2001) 3.77
How does proteinuria cause progressive renal damage? J Am Soc Nephrol (2006) 3.46
Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage. Am J Kidney Dis (2008) 2.85
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial. Lancet (2011) 2.82
Mammalian target of rapamycin inhibition as therapy for hematologic malignancies. Cancer (2004) 2.31
Rapamycin attenuates unilateral ureteral obstruction-induced renal fibrosis. Kidney Int (2006) 2.24
De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant (2004) 2.17
Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int (2006) 2.12
Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant (2005) 1.84
Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int (2002) 1.63
Noninvasive determination of carotid-femoral pulse wave velocity depends critically on assessment of travel distance: a comparison with invasive measurement. J Hypertens (2009) 1.62
Role for TGF-beta in cyclosporine-induced modulation of renal epithelial barrier function. J Am Soc Nephrol (2007) 1.52
Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients. Transplantation (2003) 1.46
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism. Transplantation (2002) 1.45
Switch of immunosuppression from cyclosporine A to everolimus: impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens (2008) 1.42
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32
Interstitial fibrosis in renal allografts after 12 to 46 months of cyclosporin treatment: beneficial effect of low doses in early post-transplantation period. Lancet (1984) 1.31
Chronic renal allograft rejection: immunologic and nonimmunologic risk factors. Kidney Int (1996) 1.20
Mortality after kidney transplant failure: the impact of non-immunologic factors. Kidney Int (2002) 1.20
Chronic allograft nephropathy: An update. Kidney Int (1999) 1.19
Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol (2010) 1.11
TGFβ- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR). J Cell Physiol (2011) 1.09
Delta analysis of posttransplantation tubulointerstitial damage. Transplantation (2004) 0.96
TGF-β in transplantation tolerance. Curr Opin Immunol (2011) 0.93
Cyclosporine-induced interstitial fibrosis and arteriolar TGF-beta expression with preserved renal blood flow. Transplantation (1999) 0.92
Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab (2002) 0.90
Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model. PLoS One (2012) 0.90
Conversion from cyclosporine to everolimus at 4.5 months posttransplant: 3-year results from the randomized ZEUS study. Am J Transplant (2012) 0.84
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions. Transplantation (2004) 0.83
Hyperuricemia in kidney transplantation. Contrib Nephrol (2005) 0.81
Relationship between uric acid and vascular structure and function in hypertensive patients and sex-related differences. Am J Hypertens (2013) 0.81
Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine. Am J Transplant (2011) 0.81
Interstitial fibrosis in renal allografts in patients treated with cyclosporin. Lancet (1984) 0.78
Activated cells in urine and monocyte chemotactic peptide-1 (MCP-1)--sensitive rejection markers in renal graft recipients. Transpl Immunol (2007) 0.77
Association of a change in immunosuppressive regimen with hemodynamic and inflammatory markers of cardiovascular disease after kidney transplantation. Am J Hypertens (2013) 0.75
Relationship between CD107a expression and cytotoxic activity. Cell Immunol (2008) 1.95
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow. Clin Exp Metastasis (2005) 1.18
Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions. J Biol Chem (2003) 1.18
Molecular diagnosis of analbuminemia: a novel mutation identified in two Amerindian and two Turkish families. Clin Chem (2002) 0.99
Diarrhoea following renal transplantation. Clin Transplant (2002) 0.98
The biological effects of 632.8-nm low energy He-Ne laser on peripheral blood mononuclear cells in vitro. J Photochem Photobiol B (2006) 0.98
Neurofilament ELISA validation. J Immunol Methods (2009) 0.96
Coronary artery calcification and coronary flow velocity in haemodialysis patients. Nephrol Dial Transplant (2010) 0.95
Effect of pathologic fractures on survival in multiple myeloma patients: a case control study. J Exp Clin Cancer Res (2008) 0.95
Osteoprotegerin/RANKL axis and progression of coronary artery calcification in hemodialysis patients. Clin J Am Soc Nephrol (2012) 0.94
Oral health and inflammation in patients with end-stage renal failure. Perit Dial Int (2009) 0.93
Cytokine levels in euthymic bipolar patients. J Affect Disord (2010) 0.93
β-Thalassemia trait association with autoimmune diseases: β-globin locus proximity to the immunity genes or role of hemorphins? Immunopharmacol Immunotoxicol (2011) 0.91
Extrapulmonary tuberculosis in immunocompetent adults. Scand J Infect Dis (2004) 0.91
FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients. BMC Nephrol (2013) 0.89
Comparative effect of oral pulse and intravenous calcitriol treatment in hemodialysis patients: the effect on serum IL-1 and IL-6 levels and bone mineral density. Nephron (2002) 0.88
Reduction of uric acid levels with allopurinol treatment improves endothelial function in patients with chronic kidney disease. Clin Nephrol (2012) 0.87
Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract (2004) 0.87
Non-convulsive status epilepticus following antibiotic therapy as a cause of unexplained loss of consciousness in patients with renal failure. Clin Exp Nephrol (2008) 0.86
Malnutrition-inflammation-atherosclerosis (MIA) syndrome components in hemodialysis and peritoneal dialysis patients. Ren Fail (2006) 0.86
Intracranial calcification and tumoural calcinosis during vitamin D therapy. Nephrology (Carlton) (2004) 0.85
Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: a single center experience. Clin Exp Nephrol (2012) 0.85
The changes in serum leptin, body fat mass and insulin resistance after renal transplantation. Clin Transplant (2003) 0.84
Pauci-immune necrotizing crescentic glomerulonephritis with crescentic and full moon extracapillary proliferation: clinico-pathologic correlation and follow-up study. Pathol Res Pract (2012) 0.84
Endothelial dysfunction in patients with asthma: the role of polymorphisms of ACE and endothelial NOS genes. J Asthma (2004) 0.84
Decreased cytokine expression in peripheral blood leukocytes of patients with severe sepsis. Arch Surg (2002) 0.83
Malignant fibrous histiocytoma of the spleen. Intern Med (2003) 0.82
Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate. Hematology (2009) 0.82
The influence of low dialysate sodium and glucose concentration on volume distributions in body compartments after haemodialysis: a bioimpedance analysis study. Nephrol Dial Transplant (2008) 0.82
Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review. Int J Hematol (2012) 0.82
Cost of renal replacement therapy in Turkey. Nephrology (Carlton) (2004) 0.81
Evidence for an association between tumor necrosis factor-alpha levels and lithium response. J Affect Disord (2012) 0.81
Major depression and psoriasis activation due to interferon-alpha in a patient with chronic myeloid leukemia; "overlooked and/or misdiagnosed adverse reaction in malignant disease". Am J Hematol (2003) 0.81
Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia. J Investig Med (2015) 0.81
IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease. Mod Rheumatol (2014) 0.81
Effect of educational level on oral health in peritoneal and hemodialysis patients. Int J Dent (2009) 0.80
Hyperuricemia is associated with progression of IgA nephropathy. Int Urol Nephrol (2015) 0.79
Effect of pre-transplant dialysis modality on kidney transplantation outcome. Perit Dial Int (2009) 0.79
Lower serum prohepcidin levels associated with lower iron and erythropoietin requirements in hemodialysis patients with chronic hepatitis C. BMC Nephrol (2012) 0.79
Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant (2008) 0.79
The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int (2003) 0.79
The decreased CD4+CD25+ FoxP3+ T cells in nonstimulated allergic rhinitis patients sensitized to house dust mites. J Asthma (2012) 0.79
Cardiac biomarkers and noninvasive predictors of atherosclerosis in chronic peritoneal dialysis patients. Kidney Blood Press Res (2012) 0.79
QT dispersion predicts mortality and correlates with both coronary artery calcification and atherosclerosis in hemodialysis patients. Int Urol Nephrol (2013) 0.78
Elevated resistin levels are associated with inflammation in hemodialysis patients with failed renal allografts. Int J Artif Organs (2014) 0.78
Stimulated salivary flow rate in chronic hemodialysis patients. Nephron (2002) 0.78
Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant (2003) 0.78
Coronary artery calcification and chronically decreased GFR in living kidney donors. Am J Kidney Dis (2007) 0.78
An ultrasensitive tumor enriched flow-cytometric assay for detection of isolated tumor cells in bone marrow of patients with breast cancer. Am J Surg (2002) 0.78
Decrease in endothelial progenitor cells associated with inflammation, but not with endothelial dysfunction in chronic hemodialysis patients. Clin Nephrol (2013) 0.78
Cardiovascular-renal changes after kidney donation: one-year follow-up study. Transplantation (2015) 0.78
Plasma concentrations of soluble cytokine receptors in euthymic bipolar patients with and without subsyndromal symptoms. BMC Psychiatry (2012) 0.78
Natural killer cells in allergic inflammation. Chem Immunol Allergy (2008) 0.78
Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients. Int J Artif Organs (2011) 0.78
Methylenetetrahydrofolate reductase C677T polymorphism and toxicity in allogeneic hematopoietic cell transplantation. Transplantation (2003) 0.78
Effects of Ganoderma lucidum on obstructive jaundice-induced oxidative stress. Asian J Surg (2010) 0.78
Dimethylarginines and inflammation markers in patients with chronic kidney disease undergoing dialysis. Clin Exp Med (2009) 0.78
Effects of spironolactone on residual renal function and peritoneal function in peritoneal dialysis patients. Adv Perit Dial (2014) 0.77
Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Chest (2002) 0.77
Behçet's disease: immunological relevance with arthritis of ankylosing spondylitis. Rheumatol Int (2012) 0.77
Evaluation of the medically complex living kidney donor. J Transplant (2012) 0.77
Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia. Leuk Res (2011) 0.77
Hypervolemia rather than arterial calcification and extracoronary atherosclerosis is the main determinant of pulse pressure in hemodialysis patients. Int Urol Nephrol (2011) 0.77
The effect of renal transplantation on pulmonary function. Nephron (2002) 0.77
The water-soluble triptolide derivative PG490-88 protects against cisplatin-induced acute kidney injury. J Pharmacol Exp Ther (2014) 0.77
Crescentic glomerulonephritis due to IgA nephropathy or propylthiouracil-induced Mpo-Anca positive vasculitis? Ren Fail (2013) 0.77
Is decline in serum albumin an ominous sign for subsequent peritonitis in peritoneal dialysis patients? Adv Perit Dial (2009) 0.77
Comparison of markers of appetite and inflammation between hemodialysis patients with and without failed renal transplants. J Ren Nutr (2011) 0.76
Analysis of activation-induced cytidine deaminase mRNA levels in patients with chronic lymphocytic leukemia with different cytogenetic status. Leuk Lymphoma (2013) 0.76
Outcomes of acute renal failure patients requiring intermittent hemodialysis. Ren Fail (2007) 0.76
Natural killer cells: versatile roles in autoimmune and infectious diseases. Expert Rev Clin Immunol (2009) 0.76
Appetite-regulating hormones in chronic kidney disease patients. J Ren Nutr (2010) 0.76
Conversion to sirolimus in renal transplant recipients: a single-center experience. Artif Organs (2010) 0.75
Working out nephronophthisis genetics one family at a time. J Am Soc Nephrol (2013) 0.75
[Prevention of radiocontrast nephropathy]. Anadolu Kardiyol Derg (2003) 0.75
Different Courses of Hepatitis B Reinfection After Renal Transplant: A Case Report. Exp Clin Transplant (2017) 0.75
Acquired ichthyosis as a presenting finding of Hodgkin's lymphoma. Int J Hematol (2012) 0.75
Tularemia in a kidney transplant recipient. Am J Kidney Dis (2012) 0.75
A Rare Clinical Entity: Staphylococcus-Related Glomerulonephritis. Exp Clin Transplant (2017) 0.75
Risk factors for persistence of asthma in children: 10-year follow-up. J Asthma (2013) 0.75
Aortic dissection presenting with abdominal pain. Intern Med (2012) 0.75
Autologous stem cells collected after debulking by high dose chemotherapy in late phase chronic myeloid leukemia may improve Imatinib efficacy. Transfus Apher Sci (2007) 0.75
A stimulatory role of ozone exposure on human natural killer cells. Immunol Invest (2013) 0.75
Nickel dental alloys can induce laryngeal edema attacks: a case report. J Dermatol (2013) 0.75
Women advancing science. Eur J Immunol (2010) 0.75